Serum Institute of India has also accorded with the Jenner Institute, to produce and develop Jenner’s R21/Matrix-M malaria shot on a large scale.
Pune: Vaccine manufacturer, Serum Institute of India, has vowed to the University of Oxford to pay an amount of 50 million pounds ($66.2 million) for setting up a research campus that would also house the institute behind the AstraZeneca-Oxford COVID-19 shot.
The company’s Serum Life Sciences unit made the investments to the University of Oxford, said the university’s authorities on Wednesday. The research building will be named after the owner of Serum Institute, .i.e. the Poonawalla Family. This vow by the institute builds the collaboration between Oxford University, AstraZeneca, and SII, the world’s largest maker of vaccines and the producer of a version of the British duo’s COVID-19 shot for low- and middle-income countries.
Serum Institute has also accorded with the Jenner Institute, to produce and develop Jenner’s R21/Matrix-M malaria shot on a large scale. The trials for this are going on, on a large scale.
SII was founded in 1966 in the Western Indian city of Pune by Cyrus Poonawalla, son of a horse breeder, and India’s fifth-richest person, according to Forbes. In 2019, Cyrus was also conferred an honorary degree by Oxford University.
It is currently run by his son Adar Poonawalla, whose wife Natasha Poonawalla heads Serum Life Sciences.
The Poonawallas in September invested 50 million pounds in Oxford Biomedica to help fund the development of a plant that manufactures COVID-19 shots.
The Oxford COVID-19 vaccine team is working at unprecedented speed in a race against the global threat to human health that is, coronavirus.
The University of Oxford’s Jenner Institute and Oxford Vaccine Group have been at the forefront of scientific endeavors to develop vaccines for diseases of major global importance for more than 30 years.
Oxford’s coronavirus vaccine has been approved for use in several countries, marking an important milestone in the fight against COVID-19.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
